The impact of influenza infection on young children, their family and the health care system.
Absenteeism
Australia
/ epidemiology
Child, Preschool
Cohort Studies
Female
Health Impact Assessment
Hospitals, Pediatric
Humans
Infant
Influenza, Human
/ drug therapy
Male
Patient Acceptance of Health Care
/ statistics & numerical data
Respiratory Tract Infections
/ drug therapy
Seasons
Surveys and Questionnaires
children
impact
influenza
influenza-like illness
Journal
Influenza and other respiratory viruses
ISSN: 1750-2659
Titre abrégé: Influenza Other Respir Viruses
Pays: England
ID NLM: 101304007
Informations de publication
Date de publication:
01 2019
01 2019
Historique:
received:
05
08
2018
accepted:
14
08
2018
pubmed:
24
8
2018
medline:
9
11
2019
entrez:
24
8
2018
Statut:
ppublish
Résumé
Influenza is a major cause of respiratory illness in young children. Assessing the impact of infection on children and the community is required to guide immunisation policies. To describe the impact of laboratory-proven influenza in young children and to compare its impact with that of other respiratory viruses on the child, their family and the health care system. Preschool children presenting for care or admission to a tertiary paediatric hospital during the 2008-2014 influenza seasons were tested for respiratory virus by polymerase chain reaction and culture. Parental surveys were used to determine the impact of infection on illness duration, medication use, absenteeism and health service utilisation. Multivariate regression analyses were used to assess the impact of influenza and to evaluate the association between influenza status and outcomes. Among 1191 children assessed, 238 had influenza. Among children with influenza, 87.8% were administered antipyretics and 40.9% antibiotics. 28.6% had secondary complications. 65.4% of children missed school/day care, and 53.4% of parents missed work. When influenza and other viruses were compared, significant differences were noted including duration of illness (influenza: 9.54 days, other viruses: 8.50 days; P = 0.005) and duration of absenteeism for both the child (23.1 vs 17.3 hours; P = 0.015) and their parents (28.5 vs 22.7 hours; P = 0.012). Influenza infection in young children has a significant impact on medication use, absenteeism and the use of health care service. Significant differences are identified when compared with other ILI. These data demonstrate that influenza prevention strategies including immunisation are likely to have wide and significant impacts.
Sections du résumé
BACKGROUND
Influenza is a major cause of respiratory illness in young children. Assessing the impact of infection on children and the community is required to guide immunisation policies.
OBJECTIVES
To describe the impact of laboratory-proven influenza in young children and to compare its impact with that of other respiratory viruses on the child, their family and the health care system.
METHODS
Preschool children presenting for care or admission to a tertiary paediatric hospital during the 2008-2014 influenza seasons were tested for respiratory virus by polymerase chain reaction and culture. Parental surveys were used to determine the impact of infection on illness duration, medication use, absenteeism and health service utilisation. Multivariate regression analyses were used to assess the impact of influenza and to evaluate the association between influenza status and outcomes.
RESULTS
Among 1191 children assessed, 238 had influenza. Among children with influenza, 87.8% were administered antipyretics and 40.9% antibiotics. 28.6% had secondary complications. 65.4% of children missed school/day care, and 53.4% of parents missed work. When influenza and other viruses were compared, significant differences were noted including duration of illness (influenza: 9.54 days, other viruses: 8.50 days; P = 0.005) and duration of absenteeism for both the child (23.1 vs 17.3 hours; P = 0.015) and their parents (28.5 vs 22.7 hours; P = 0.012).
CONCLUSIONS
Influenza infection in young children has a significant impact on medication use, absenteeism and the use of health care service. Significant differences are identified when compared with other ILI. These data demonstrate that influenza prevention strategies including immunisation are likely to have wide and significant impacts.
Identifiants
pubmed: 30137663
doi: 10.1111/irv.12604
pmc: PMC6304317
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
18-27Informations de copyright
© 2018 The Authors. Influenza and Other Respiratory Viruses Published by John Wiley & Sons Ltd.
Références
J Infect. 2011 May;62(5):379-87
pubmed: 21414357
Vaccine. 2006 Aug 14;24(33-34):5970-6
pubmed: 16759761
Pediatr Infect Dis J. 2011 Feb;30(2):107-11
pubmed: 21079528
J Clin Microbiol. 2010 Mar;48(3):862-6
pubmed: 20071557
J Virol Methods. 2010 Oct;169(1):47-51
pubmed: 20600329
BMC Public Health. 2012 Nov 12;12:968
pubmed: 23146107
Vaccine. 2006 Jun 5;24(23):4934-41
pubmed: 16678945
Influenza Other Respir Viruses. 2010 Jul;4(4):231-4
pubmed: 20629773
N Engl J Med. 2006 Jul 6;355(1):31-40
pubmed: 16822994
J Infect Dis. 2004 Oct 15;190(8):1369-73
pubmed: 15378427
Pediatr Infect Dis J. 2016 Mar;35(3):309-15
pubmed: 26646548
J Paediatr Child Health. 2009 Dec;45(12):698-703
pubmed: 19895431
PLoS One. 2013 Jun 03;8(6):e64734
pubmed: 23755139
Vaccine. 2008 Sep 12;26 Suppl 4:D45-8
pubmed: 19230159
Influenza Other Respir Viruses. 2019 Jan;13(1):18-27
pubmed: 30137663
Arch Dis Child. 2004 Nov;89(11):1002-7
pubmed: 15499051
Commun Dis Intell Q Rep. 2010 Dec;34 Supp:S1-167
pubmed: 21416762
Pediatrics. 2014 May;133(5):e1218-25
pubmed: 24753525
Drugs. 2014 Sep;74(13):1467-79
pubmed: 25150045
Vaccine. 2008 Dec 9;26(52):6818-23
pubmed: 18940222
Vaccine. 2011 Oct 6;29(43):7524-8
pubmed: 21820476
Pediatrics. 2007 Oct;120(4):e929-37
pubmed: 17875651
Pediatrics. 2003 Aug;112(2):363-7
pubmed: 12897288
J Pediatr. 2009 Mar;154(3):447-9
pubmed: 19874761
J Pediatric Infect Dis Soc. 2013 Mar;2(1):21-9
pubmed: 26619439
JAMA. 1996 Jan 24-31;275(4):300-4
pubmed: 8544270
Vaccine. 2006 Jan 30;24(5):629-35
pubmed: 16157429
Methods Mol Biol. 2011;665:415-33
pubmed: 21116813
Clin Microbiol Infect. 2005 Nov;11(11):933-6
pubmed: 16216113
Influenza Other Respir Viruses. 2013 Nov;7(6):1103-12
pubmed: 23829670
Pharmacoeconomics. 2012 Aug 1;30(8):647-60
pubmed: 22788257
Viruses. 2009 Jun;1(1):42-56
pubmed: 21994537
Euro Surveill. 2016 Jul 28;21(30):
pubmed: 27494798
Influenza Other Respir Viruses. 2014 Nov;8(6):636-45
pubmed: 25263176